PFEPfizer
Pfizer Inc. is a research-based, global biopharmaceutical company. 10-K, Item 1
- Employees
- 75,000
- Headquarters
- New York, NY
- CEO
- Albert Bourla
- Next results
- around Feb 2, 2027
Numbers in PFE's annual reports that a later 10-K reports differently for the same year and the same XBRL line item, fiscal years since 2020, changes of 0.5% or more. A change is a restatement (the company says the earlier number was wrong, in an 8-K item 4.02) or a recast: after selling a business, adopting an accounting rule or moving amounts between lines, companies redo past years. The later 10-K's notes say which.
| Number | Period | First reported | Later reported | Change | Why |
|---|---|---|---|---|---|
| Receivables AccountsReceivableNetCurrent · link |
At 2023-12-31 | $11.18B 10-K filed 2024-02-22 |
$11.57B 10-K filed 2025-02-27 |
+3.5% | Recast or revision |
| Revenue RevenueFromContractWithCustomerExcludingAssessedTax · link |
Fiscal year ending 2021-12-31 | $81.29B 10-K filed 2022-02-24 |
$73.64B 10-K filed 2024-02-22 |
-9.4% | Recast or revision |
| Revenue RevenueFromContractWithCustomerExcludingAssessedTax · link |
Fiscal year ending 2020-12-31 | $41.91B 10-K filed 2021-02-25 |
$41.65B 10-K filed 2022-02-24 |
-0.6% | Recast or revision |
| Net income NetIncomeLoss · link |
Fiscal year ending 2020-12-31 | $9.62B 10-K filed 2021-02-25 |
$9.16B 10-K filed 2022-02-24 |
-4.8% | Recast or revision |
From SEC's XBRL company facts (6 10-K filings). Checked: revenue, operating income, net income, cash from operations, total assets, shareholders' equity, receivables and inventory. Per-share numbers are left out because stock splits change them.
Work on PFE in a spreadsheet:
Excel workbook (a sheet per section, ten years by column, charts, links to the filings) ·
CSV.
For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/PFE/export.csv") into a cell.